Stryker Corporation (SYK) Upgraded to Outperform at BMO Capital

Market Context

Stryker Corporation operates in the Healthcare sector. The stock currently trades at $327.11 with a market capitalization of $135.0B. The stock has declined 7.6% over the past 52 weeks.

Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. BMO Capital's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Stryker Corporation

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 09, 2026	BMO Capital	Outperform	N/A
Jul 06, 2026	Evercore ISI Group	Outperform	N/A
Jun 05, 2026	Leerink Partners	Outperform	N/A
May 04, 2026	Barclays	Overweight	N/A
May 04, 2026	Truist Securities	Hold	N/A

Related Tools: Analyst Ratings Dashboard | View SYK Stock Page